Clinical Trial: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712562) titled 'A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes' on July 14.

Brief Summary: This is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Bone Marrow Failure Syndromes Aplastic Anemias Severe Aplastic Anemia (SAA) Severe Aplastic Anemia, Relapse Severe Aplastic Anemia, Refractory Non-severe Aplastic Anemia

Intervention: DRUG: Dibotatug (DR-01)

Dibotatug (DR-01) administered by IV infusion

Re...